{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:18:42Z","timestamp":1793056722979,"version":"4.5.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Spectral flow cytometry has ushered in a new era in immunology. Through the improvement of the resolution of surface and intracellular protein expression, this approach enables in depth characterization of rare immune cell subsets, such as innate lymphoid cells (ILCs), in health and disease. Due to their heterogeneity, the identification of ILCs requires the use of many lineage marker antibodies for non-ILC exclusion, together with the analysis of several transcription factor expression profiles for ILC subset distinction. Such intricacies toward their identification and their scarcity in tissues have been key factors directly limiting their characterization, particularly during tumor development and progression. We developed, optimized and validated a 25-parameter spectral flow cytometric panel for the identification of mouse ILC subsets and characterization of their phenotype and proliferation capabilities in mouse mammary tumors. The use of conjugated antibodies coupled to different fluorochromes for the analysis of lineage marker expression further allows the identification and characterization of \u03b3\u03b4 T cells, CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u03b1\u03b2 T cells, as well as CD19\n                    <jats:sup>+<\/jats:sup>\n                    B cells. Furthermore, we built a bioinformatics pipeline for unbiased immune cell clustering and marker expression analysis. We assessed this panel and downstream bioinformatics analyses on two spectral flow cytometers and found no difference in immune cell identification and clustering save for slight variations in marker intensity, inherent to the specificities of the instrument. These findings highlight the robustness of our developed approach for the identification of innate lymphoid cells in tumors, a method that can be easily implemented for day-to-day analysis of ILCs and other rare immune cell subsets.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1730567","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:41:45Z","timestamp":1769496105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Development and computational analysis of high dimensional spectral flow cytometry data for the resolution of innate lymphoid cells in the mammary tumor microenvironment"],"prefix":"10.3389","volume":"17","author":[{"given":"Hobin","family":"Seo","sequence":"first","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingna","family":"Xue","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiutong","family":"Huang","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kinzel","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amisha","family":"Verma","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngan","family":"Huynh","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Jamila Ikra","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas J.","family":"Mahoney","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Alberta Children\u2019s Hospital Research Institute","place":["Calgary, AB, Canada"]},{"name":"Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongbok","family":"Lee","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Alberta Children\u2019s Hospital Research Institute","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorana","family":"Morrissy","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Alberta Children\u2019s Hospital Research Institute","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jacquelot","sequence":"additional","affiliation":[{"name":"Riddell Centre for Cancer Immunotherapy, Arnie Charbonneau Cancer Institute, Arthur J.E. Child Comprehensive Cancer Centre, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Biochemistry & Molecular Biology, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Department of Microbiology, Immunology & Infectious Diseases, Cumming School of Medicine, University of Calgary","place":["Calgary, AB, Canada"]},{"name":"Alberta Children\u2019s Hospital Research Institute","place":["Calgary, AB, Canada"]},{"name":"Calvin, Phoebe, and Joan Snyder Institute for Chronic Diseases, University of Calgary","place":["Calgary, AB, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1002\/eji.202170126","article-title":"Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)","volume":"51","author":"Cossarizza","year":"2021","journal-title":"Eur J Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24566","article-title":"The evolution of spectral flow cytometry","volume":"101","author":"Nolan","year":"2022","journal-title":"Cytometry A"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24841","article-title":"OMIP-102: 50-color phenotyping of the human immune system with in-depth assessment of T cells and dendritic cells","volume":"105","author":"Konecny","year":"2024","journal-title":"Cytometry A"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24288","article-title":"Development of a 43 color panel for the characterization of conventional and unconventional T-cell subsets, B cells, NK cells, monocytes, dendritic cells, and innate lymphoid cells using spectral flow cytometry","volume":"105","author":"Sahir","year":"2020","journal-title":"Cytometry A"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24031","article-title":"OMIP-064: A 27-color flow cytometry panel to detect and characterize human NK cells and other innate lymphoid cell subsets, MAIT cells, and \u03b3\u03b4 T cells","volume":"97","author":"Hertoghs","year":"2020","journal-title":"Cytometry A"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24702","article-title":"OMIP-086: Full spectrum flow cytometry for high-dimensional immunophenotyping of mouse innate lymphoid cells","volume":"103","author":"Mincham","year":"2023","journal-title":"Cytometry A"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3489","article-title":"Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis","volume":"17","author":"Klose","year":"2016","journal-title":"Nat Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01127-z","article-title":"Innate lymphoid cells and cancer","volume":"23","author":"Jacquelot","year":"2022","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.3390\/pharmaceutics15072001","article-title":"Targeting potential of innate lymphoid cells in melanoma and other cancers","volume":"15","author":"Seo","year":"2023","journal-title":"Pharmaceutics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01883-0","article-title":"High-dimensional single-cell analysis of human natural killer cell heterogeneity","volume":"25","author":"Rebuffet","year":"2024","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.xcrm.2022.100812","article-title":"Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells","volume":"3","author":"Lopes","year":"2022","journal-title":"Cell Rep Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00445-x","article-title":"Tissue-specific transcriptional imprinting and heterogeneity in human innate lymphoid cells revealed by full-length single-cell RNA-sequencing","volume":"31","author":"Mazzurana","year":"2021","journal-title":"Cell Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00704-5","article-title":"Heterogeneity of type 2 innate lymphoid cells","volume":"22","author":"Spits","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"100353","DOI":"10.1016\/j.xcrm.2021.100353","article-title":"Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression","volume":"2","author":"Qi","year":"2021","journal-title":"Cell Rep Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836999","article-title":"Tissue-dependent adaptations and functions of innate lymphoid cells","volume":"13","author":"Murphy","year":"2022","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2020.08.009","article-title":"Tissue-specific features of innate lymphoid cells","volume":"41","author":"Meininger","year":"2020","journal-title":"Trends Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.12.3.954-961.1992","article-title":"Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease","volume":"12","author":"Guy","year":"1992","journal-title":"Mol Cell Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-01560-0","article-title":"Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo","volume":"40","author":"Attalla","year":"2021","journal-title":"Oncogene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.mcb.2024.03.008","article-title":"Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors","volume":"192","author":"Chung","year":"2025","journal-title":"Methods Cell Biol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-106","article-title":"flowCore: flowCore: Basic structures for flow cytometry data","volume":"10","author":"Ellis","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btn021","article-title":"Using flowViz to visualize flow cytometry data","volume":"24","author":"Sarkar","year":"2008","journal-title":"Bioinformatics"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13790","article-title":"A systematic review of tools for determining activity of localized scleroderma in paediatric and adult patients","volume":"31","author":"Lis-\u015awi\u0119ty","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24501","article-title":"PeacoQC: Peak-based selection of high quality cytometry data","volume":"101","author":"Emmaneel","year":"2022","journal-title":"Cytometry A"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.23904","article-title":"CytoNorm: A normalization algorithm for cytometry data","volume":"97","author":"Van Gassen","year":"2020","journal-title":"Cytometry A"},{"key":"B26","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1158\/2767-9764.CRC-23-0357","article-title":"Spectral flow cytometry methods and pipelines for comprehensive immunoprofiling of human peripheral blood and bone marrow","volume":"4","author":"Spasic","year":"2024","journal-title":"Cancer Res Commun"},{"key":"B27","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"B28","article-title":"Phenoflow: A microservice architecture for portable workflow-based phenotype definitions","volume":"2021","author":"Chapman","year":"2021","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat Methods"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.24046","article-title":"OMIP-066: identification of novel subpopulations of human group 2 innate lymphoid cells in peripheral blood","volume":"97","author":"Ohne","year":"2020","journal-title":"Cytometry Pt A"},{"key":"B31","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cyto.a.24529","article-title":"OMIP 082: A 25-color phenotyping to define human innate lymphoid cells, natural killer cells, mucosal-associated invariant T cells, and \u03b3\u03b4 T cells from freshly isolated human intestinal tissue","volume":"101","author":"Doyle","year":"2022","journal-title":"Cytometry Pt A"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.8.4764","article-title":"NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation","volume":"178","author":"Huntington","year":"2007","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e70009","DOI":"10.1002\/eji.70009","article-title":"LAG3 marks activated but hyporesponsive NK cells","volume":"55","author":"Vasilyeva","year":"2025","journal-title":"Eur J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00943-z","article-title":"Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma","volume":"22","author":"Jacquelot","year":"2021","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00867-9","article-title":"Insights from a 30-year journey: function, regulation and therapeutic modulation of PD1","volume":"23","author":"Chamoto","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.612801","article-title":"Full spectrum flow cytometry as a powerful technology for cancer immunotherapy research","volume":"7","author":"Bonilla","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.827987","article-title":"Using the autofluorescence finder on the sony ID7000TM spectral cell analyzer to identify and unmix multiple highly autofluorescent murine lung populations","volume":"10","author":"Wanner","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.768113","article-title":"How to prepare spectral flow cytometry datasets for high dimensional data analysis: A practical workflow","volume":"12","author":"Den Braanker","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw191","article-title":"flowAI: automatic and interactive anomaly discerning tools for flow cytometry data","volume":"32","author":"Monaco","year":"2016","journal-title":"Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.a.22837","article-title":"flowClean: Automated identification and removal of fluorescence anomalies in flow cytometry data","volume":"89","author":"Fletez-Brant","year":"2016","journal-title":"Cytometry A"},{"key":"B41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/cyto.a.24670","article-title":"flowCut: An R package for automated removal of outlier events and flagging of files based on time versus fluorescence analysis","volume":"103","author":"Meskas","year":"2023","journal-title":"Cytometry A"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730567\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:31:45Z","timestamp":1771921905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1730567\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2026.1730567"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1730567","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1730567"}}